Europe

Europe

The latest European Pharmaceutical industry news

Europe Plans Further Antibiotic Shortage CountermeasuresEurope Plans Further Antibiotic Shortage Countermeasures
Europe Plans Further Antibiotic Shortage Countermeasures

Following the increase in respiratory infections, the continuing cost of living crisis and the Russia-Ukraine conflict, Europe is planning countermeasures for further antibiotic shortages

Mar 6, 2023 Europe
AstraZeneca Moves Manufacturing To Ireland Due To Britain’s Tax RegimeAstraZeneca Moves Manufacturing To Ireland Due To Britain’s Tax Regime
AstraZeneca Moves Manufacturing To Ireland Due To Britain’s Tax Regime

AstraZeneca has announced plans to open a new facility in Ireland, previously planned for northwest England

Mar 6, 2023 Europe
Genoscience Pharma Received Orphan Drug Designation For Hepatocellular Carcinoma DrugGenoscience Pharma Received Orphan Drug Designation For Hepatocellular Carcinoma Drug
Genoscience Pharma Received Orphan Drug Designation For Hepatocellular Carcinoma Drug

Genoscience Pharma has received FDA ODD for its hepatocellular carcinoma drug

Mar 6, 2023 Europe
European Commission Approves Dupixent® As The First And Only Targeted Medicine For Prurigo NodularisEuropean Commission Approves Dupixent® As The First And Only Targeted Medicine For Prurigo Nodularis
European Commission Approves Dupixent® As The First And Only Targeted Medicine For Prurigo Nodularis

Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in the European Union to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.

Feb 1, 2023 Europe
ServBlock Secures EU Funding For Pharma Manufacturing Data SpaceServBlock Secures EU Funding For Pharma Manufacturing Data Space
ServBlock Secures EU Funding For Pharma Manufacturing Data Space

ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system for outsourced pharmaceutical manufacturing.

Feb 1, 2023 Europe
Astrazeneca Shares Two New Drug Approvals In The EUAstrazeneca Shares Two New Drug Approvals In The EU
Astrazeneca Shares Two New Drug Approvals In The EU

Recently, AstraZeneca announced two drug approvals in the European Union (EU), the first being Imfinzi’s approval for the treatment of biliary tract cancer, and the latter being Lynparza for prostate cancer.

Feb 1, 2023 Europe
Molecure Sees Positive Outcomes In Clinical Trials And Announces Financial ResultsMolecure Sees Positive Outcomes In Clinical Trials And Announces Financial Results
Molecure Sees Positive Outcomes In Clinical Trials And Announces Financial Results

Polish clinical stage biotechnology company Molecure has announced its third quarter results for the period ending 30 September 2022. Its press release also mentions its plans for its R&D day in December, and its strategies and preparations for various phase 1 and 2 clinical trials.

Dec 1, 2022 Europe
European Commission Gives Orphan Status To Selinexor To Treat MyelofribrosisEuropean Commission Gives Orphan Status To Selinexor To Treat Myelofribrosis
European Commission Gives Orphan Status To Selinexor To Treat Myelofribrosis

Karyopharm Therapeutics and the Menarini Group’s Nexpovio (selinexor) has been granted orphan medicinal product designation by the European Commission (EC). The drug is intended to treat myelofibrosis (MF), a rare kind of bone marrow cancer.

Dec 1, 2022 Europe
EU Approval Recommended For Three Drugs From AstrazenecaEU Approval Recommended For Three Drugs From Astrazeneca
EU Approval Recommended For Three Drugs From Astrazeneca

AstraZeneca has announced that three of its drugs have been recommended for EU approval. The three drugs are: Imfinzi, Enhertu and Lynparza, all of which can be used to treat different cancers.

Dec 1, 2022 Europe
Yeast Cells Engineered To Fight CancerYeast Cells Engineered To Fight Cancer
Yeast Cells Engineered To Fight Cancer

A team of scientists at the Technical University of Denmark have genetically engineered yeast to recreate vinblastine, an anti-cancer drug which was in short supply between 2019-2021. It is hoped this breakthrough will pave the way to creating more synthetic anti-cancer drugs.

Oct 27, 2022 Europe
Roche Agrees To Buy Good TherapeuticsRoche Agrees To Buy Good Therapeutics
Roche Agrees To Buy Good Therapeutics

The Swiss pharma group has agreed to buy Seattle-based biotech Good Therapeutics and its preclinical-stage PD-1 regulated IL-2 receptor agonist programme for $250 million upfront, with undisclosed milestone payments on offer tied to development, regulatory, and commercial objectives.

Oct 27, 2022 Europe
Baby Sticky Tape Skin Test Could Predict Risk Of EczemaBaby Sticky Tape Skin Test Could Predict Risk Of Eczema
Baby Sticky Tape Skin Test Could Predict Risk Of Eczema

A team of scientists from the University of Copenhagen, Denmark have designed a sticky tape skin test which could help predict if young babies are likely to develop bad eczema, according to BBC News.

Oct 27, 2022 Europe